Washington, DC 10/4/10—DNA sequencer developer Pacific Biosciences has updated its IPO filing with the SEC, stating that it plans to offer 12,500,000 shares of common stock at a price of $15–$17 per share. The company expects proceeds of $182.5 million. Of this amount, $60–$70 million would be used for applications of SMRT technologies, $40–$60 million […]
London, UK 10/8/10; London, UK 10/13/10—Instem Life Science Systems, a developer of software for early drug-development safety assessment, has commenced trading of its stock on the London Stock Exchange’s AIM market. The company raised £9.15 million ($14.5 million = £0.63 = $1) through a placement of 5,228,376 new ordinary shares at a price of £0.175 […]
Kalispell, MT 10/5/10—Applied Instruments Technologies (AIT) has been acquired from Hamilton Sundstrand by the Thompson Group of Companies for an undisclosed amount. AIT is a manufacturer and marketer of process analytical instruments, including the Analect FTIR, MGA MS and FXi GC systems. “The opportunity to organize AIT as a standalone company will allow us to […]
Spending by US universities on science and engineering (S&E) R&D grew 5.8% to $54,935 million in fiscal 2009 (ended September 30, 2009), according to a survey of 711 institutions by the National Science Foundation (NSF). Such spending accelerated last year, compared with fiscal 2008, when it grew 4.9%. Adjusted for inflation, fiscal 2009 expenditures rose […]
Although the macroeconomic outlook remains positive, signs of slowing worldwide growth have increased uncertainty among businesses. This uncertainty is reflected in the latest IBO Business Climate Survey. Instrument and lab product sales are expected to be stable, but the fallout from the global recession continues to affect growth. Also, intellectual property concerns related to doing […]
The number of US biotech companies has decreased by 25% in the past three years. Fifty-five biotech companies were acquired in 2008, up from 40 in 2007. In 2009, 38 companies were acquired. So far this year, there have been 21 acquisitions of biotech companies. Despite the decrease, the approximately 294 public biotech companies are […]
Pay Invoice
Latest Blogs
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
-
10x Genomics Debuts First Plate-Based Assay
November 21, 2025 3:50 pm
-
Lab Tool Companies and Share Repurchases
October 30, 2025 4:15 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
